Related references
Note: Only part of the references are listed.Elevated HbA1c levels in pre-Covid-19 infection increases the risk of mortality: A sistematic review and meta-analysis
Francesco Prattichizzo et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2022)
Haemoglobin A1c is a predictor of COVID-19 severity in patients with diabetes
Eugene Merzon et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2021)
Metformin Use Is Associated With Reduced Mortality in a Diverse Population With COVID-19 and Diabetes
Andrew B. Crouse et al.
FRONTIERS IN ENDOCRINOLOGY (2021)
Outpatient metformin use is associated with reduced severity of COVID-19 disease in adults with overweight or obesity
Carolyn T. Bramante et al.
JOURNAL OF MEDICAL VIROLOGY (2021)
Risks of and risk factors for COVID-19 disease in people with diabetes: a cohort study of the total population of Scotland
Stuart J. McGurnaghan et al.
LANCET DIABETES & ENDOCRINOLOGY (2021)
Racial and Ethnic Disparities in SARS-CoV-2 Testing and COVID-19 Outcomes in a Medicaid Managed Care Cohort
Mireille Jacobson et al.
AMERICAN JOURNAL OF PREVENTIVE MEDICINE (2021)
Association Between Glucagon-Like Peptide 1 Receptor Agonist and Sodium-Glucose Cotransporter 2 Inhibitor Use and COVID-19 Outcomes
Anna R. Kahkoska et al.
DIABETES CARE (2021)
Both high and low pre-infection glucose levels associated with increased risk for severe COVID-19: New insights from a population-based study
Michal Shauly-Aharonov et al.
PLOS ONE (2021)
Clinical Characterization and Prediction of Clinical Severity of SARS-CoV-2 Infection Among US Adults Using Data From the US National COVID Cohort Collaborative
Tellen D. Bennett et al.
JAMA NETWORK OPEN (2021)
Unusually High Risks of COVID-19 Mortality with Age-Related Comorbidities: An Adjusted Meta-Analysis Method to Improve the Risk Assessment of Mortality Using the Comorbid Mortality Data
Andrew Antos et al.
INFECTIOUS DISEASE REPORTS (2021)
The dynamics of inflammatory markers in coronavirus disease-2019 (COVID-19) patients: A systematic review and meta-analysis
Roshan Kumar Mahat et al.
CLINICAL EPIDEMIOLOGY AND GLOBAL HEALTH (2021)
The National COVID Cohort Collaborative (N3C): Rationale, design, infrastructure, and deployment
Melissa A. Haendel et al.
JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION (2021)
COVID-19 and diabetes mellitus: from pathophysiology to clinical management
Soo Lim et al.
NATURE REVIEWS ENDOCRINOLOGY (2021)
Metformin Treatment Was Associated with Decreased Mortality in COVID-19 Patients with Diabetes in a Retrospective Analysis
Pan Luo et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2020)
Association of Blood Glucose Control and Outcomes in Patients with COVID-19 and Pre-existing Type 2 Diabetes
Lihua Zhu et al.
CELL METABOLISM (2020)
Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study
Bertrand Cariou et al.
DIABETOLOGIA (2020)
Diabetes and COVID-19: Risks, Management, and Learnings From Other National Disasters
Jamie Hartmann-Boyce et al.
DIABETES CARE (2020)
Preadmission Diabetes-Specific Risk Factors for Mortality in Hospitalized Patients With Diabetes and Coronavirus Disease 2019
Shivani Agarwal et al.
DIABETES CARE (2020)
Glycosylated hemoglobin is associated with systemic inflammation, hypercoagulability, and prognosis of COVID-19 patients
Zhenzhou Wang et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2020)
COVID-19 in people with diabetes: understanding the reasons for worse outcomes
Matteo Apicella et al.
LANCET DIABETES & ENDOCRINOLOGY (2020)
Risk factors for COVID-19-related mortality in people with type 1 and type 2 diabetes in England: a population-based cohort study
Naomi Holman et al.
LANCET DIABETES & ENDOCRINOLOGY (2020)
Factors associated with COVID-19-related death using OpenSAFELY
Elizabeth J. Williamson et al.
NATURE (2020)
Impact of glycemic control in diabetes mellitus on management of COVID-19 infection
Sudhir Bhandari et al.
INTERNATIONAL JOURNAL OF DIABETES IN DEVELOPING COUNTRIES (2020)
Effects of underlying morbidities on the occurrence of deaths in COVID-19 patients: A systematic review and meta-analysis
Md Mostaured Ali Khan et al.
JOURNAL OF GLOBAL HEALTH (2020)
125: The Association Between HbA1C and Outcomes in COVID-19 Patients
Pamir Mateen et al.
CRITICAL CARE MEDICINE (2020)
Possible Correlations between Atherosclerosis, Acute Coronary Syndromes and COVID-19
Oliwia Grzegorowska et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Glycemic Characteristics and Clinical Outcomes of COVID-19 Patients Hospitalized in the United States
Bruce Bode et al.
JOURNAL OF DIABETES SCIENCE AND TECHNOLOGY (2020)
Inflammatory markers and control of type 2 diabetes mellitus
Hanan Elimam et al.
DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS (2019)
Association between Inflammation and Biological Variation in Hemoglobin A1c in US Nondiabetic Adults
Shuqian Liu et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2015)
Updating and Validating the Charlson Comorbidity Index and Score for Risk Adjustment in Hospital Discharge Abstracts Using Data From 6 Countries
Hude Quan et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2011)
Influence of Duration of Diabetes, Glycemic Control, and Traditional Cardiovascular Risk Factors on Early Atherosclerotic Vascular Changes in Adolescents and Young Adults with Type 2 Diabetes Mellitus
Amy S. Shah et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
10-year follow-up of intensive glucose control in type 2 diabetes
Rury R. Holman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Diabetes and vascular disease -: Pathophysiology, clinical consequences, and medical therapy:: Part I
MA Creager et al.
CIRCULATION (2003)
Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study
IM Stratton et al.
BMJ-BRITISH MEDICAL JOURNAL (2000)